BMAL Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of BMAL Antibodies for research in circadian rhythm regulation and related biological processes. BMAL Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BMAL1, a key component of the circadian clock, plays a crucial role in regulating gene expression in response to light and dark cycles, influencing numerous physiological processes such as sleep-wake cycles, metabolism, and hormone regulation. Understanding BMAL1 function is essential for elucidating the mechanisms underlying circadian rhythms and their impact on health and disease. BMAL1 research has revealed significant insights into sleep disorders, metabolic conditions, and various pathological states. Ongoing studies continue to uncover new roles for BMAL1 in cellular processes and tissue homeostasis. Recent findings highlight BMAL1's involvement in immune system regulation and cancer development. Characterization of BMAL1 has opened new avenues for therapeutic interventions in circadian rhythm disorders. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of circadian biology and its implications for human health.